Female Hair Loss Treatment: Is Minoxidil Enough? | INEE Clinic
Key points
•Topical minoxidil is the best-supported starting point for female pattern hair loss, but not every patient achieves sufficient improvement.
•Oral minoxidil, hormone-modifying treatment, PRP, microneedling and light therapy require consideration of benefits, side effects and evidence limitations.
•Treatment planning, including transplantation, depends on age, progression, donor hair, pregnancy potential and previous treatment response.
INEE INSIGHTHAIR & SCALP
Female Hair Loss TreatmentIs Minoxidil Enough?INEE Clinic
From oral minoxidil and PRP to light therapy and hair transplantation: understanding the options and evidence for female pattern hair loss
When you search for female hair loss treatment, minoxidil is usually the first medication you encounter.
Does that mean minoxidil alone is all that women with hair loss need?
A review of treatments for female pattern hair loss published in 2023 suggests otherwise.
The review identifies topical minoxidil as the treatment with the strongest body of evidence. It also explains that approximately 30–60% of women using minoxidil do not achieve sufficient improvement. The abstract summarizes this figure as approximately 40%.[1]
The practical question in female hair loss treatment is therefore this:
Beyond “Does minoxidil work?”
“What can we do for patients for whom minoxidil alone is not enough?”
01
Female pattern hair loss and standard treatment
Minoxidil is a starting point, not the end of every treatment plan
Female pattern hair loss is a condition in which follicles gradually become smaller and hair becomes finer, reducing density at the crown and along the part.
FIG. 01Changes that occur together in female pattern hair loss
01 · FOLLICLE
Gradually smaller follicles
02 · HAIR
Finer hair strands
03 · DENSITY
Reduced crown and part-line density
A simplified illustration of female pattern hair loss. Actual patterns and severity vary between individuals.
However, the process is not identical in every woman.
Genetic and environmental factors are known to be involved, alongside the influence of androgens, and the mechanisms of female pattern hair loss are not yet fully understood. It is therefore difficult to expect one treatment to work equally well for all women.
Topical minoxidil remains a recommended first-line treatment because it has the most substantial research support for its effectiveness.
In clinical practice, however, many patients find it difficult to continue treatment because the response is insufficient, daily scalp application is inconvenient, or scalp irritation occurs.
These are the patients for whom there is a reason to consider other treatments.
FIG. 02A basic framework for choosing treatment
STARTING POINTTopical minoxidilConsider a standard treatment with substantial evidence
→
REASSESSResponse & persistenceAssess effectiveness, convenience, and scalp irritation together
→
NEXT OPTIONIndividual adjustmentReview other medications or adjuncts according to individual needs
This does not mean that every patient should follow the same sequence or combination.
02
Another medication option for women
Oral minoxidil can also be a practical alternative
Low-dose oral minoxidil is one of the treatments attracting increasing interest for female hair loss.
In a study discussed in the review, hair density increased with both oral and topical minoxidil, with no statistically significant difference between them. Another study suggested that higher oral minoxidil doses may be associated with a better response.[1]
Oral minoxidil does, of course, require consideration of side effects such as excessive hair growth, swelling, and palpitations.
Rather than simply calling it “better than topical treatment,” it is more appropriate to view it as another option for patients who find topical treatment inconvenient or do not respond sufficiently.
FIG. 03Topical and oral treatment: different considerations
A standard starting point
Topical minoxidil
A substantial body of evidence supports its effectiveness.
Assess the response, the burden of daily application, and scalp irritation.
An individual alternative
Oral minoxidil
An option when topical treatment is inconvenient or insufficient.
Assess systemic side effects, including excessive hair growth, swelling, and palpitations.
Both treatments increased hair density in the comparison study, but no statistically significant difference was found.
The absence of a statistically significant difference does not establish that the treatments are equally effective.
A clinician should determine whether oral treatment is appropriate and select the dose with side effects and overall health in mind.
03
Treatments that modify hormonal influences
When the response is insufficient, consider other mechanisms
Depending on the individual, treatments that modify hormonal influences may also be considered for female pattern hair loss.
However, medications used for male pattern hair loss should not simply be applied to women in the same way. In women, age, menopausal status, signs of excess androgens, and the possibility of pregnancy must be considered together.
Some antiandrogen treatments have restrictions for women who could become pregnant, making careful patient selection particularly important.
Female hair loss treatment therefore requires an assessment of which mechanisms matter most for the individual, rather than a search for the strongest medication.
FIG. 04Four factors to consider before hormone-modifying treatment
01Age
02Menopausal status
ASSESS TOGETHERIndividual mechanisms
03Signs of excess androgens
04Pregnancy potential
Assess whether the treatment mechanism fits the individual’s circumstances.
04
PRP, microneedling, and low-level light therapy
Injection and procedural treatments cannot simply be dismissed as unsupported
Platelet-rich plasma (PRP) is a representative example.
In a randomized controlled trial involving women with female pattern hair loss, photographic assessment at 24 weeks showed improvement in 57% of the PRP group, compared with 7% of the saline group.[2]
FIG. 05Patients with photographic improvement in a PRP study24-week assessment
Randomized controlled trial enrolling 30 women · Blinded photographic assessment
PRP group
57%
Saline group
7%
050100%
What the numbers mean: The percentage of patients whose photographs showed improvement in this study. This does not mean a 57% increase in hair or a universal success rate for PRP. Two participants were lost to follow-up.[2]
A meta-analysis of 15 clinical trials in androgenetic alopecia also reported an increase in hair density.[1]
It is therefore inaccurate to describe PRP simply as a treatment with no supporting evidence.
However, blood preparation, centrifugation, platelet concentration, and treatment frequency differ between studies, and protocols are not yet sufficiently standardized.
The review likewise describes PRP as a promising adjunctive treatment for female pattern hair loss.
The situation is similar for scalp stimulation using microneedling.
Although the quality of the research cannot yet be considered high, studies in women with female pattern hair loss have reported increased hair density. The authors describe it as an adjunctive option for women who do not respond sufficiently to existing treatment or do not want standard treatment.
The review also presents low-level light therapy as an adjunctive treatment for female pattern hair loss, or as an alternative for patients who do not want medication or surgery.
FIG. 06Consider both the potential and the limitations
Platelet-rich plasma · PRP
Positive clinical findings exist. Preparation, concentration, and treatment frequency are not yet standardized.
Scalp microneedling
Increased hair density has been reported. Research quality and supporting evidence remain limited.
Low-level light therapy
May be considered as an adjunct, or when a patient does not want medication or surgery.
These treatments do not necessarily have the same level of evidence or the same effects. Their necessity and combination should be assessed individually.
05
How to interpret treatment evidence
Evidence is not simply a matter of “yes” or “no”
This is one of the most important points in understanding female hair loss treatment.
Treatments do not fall into just two categories: “proven to work” and “ineffective.”
Some have accumulated substantial evidence from many randomized trials. Others have positive trials but relatively few studies. Still others are in the early stages of evaluating their potential.
FIG. 07Different amounts of evidence have accumulated
Substantial evidenceEffects repeatedly evaluated in multiple clinical trials
Limited but positivePositive results, with limits in study number or size
Early evaluationMore research on who benefits and how to apply treatment
Less evidence≠No effect
A conceptual illustration of differences in accumulated evidence, not a formal grading of specific treatments.
A lower level of evidence does not necessarily mean that a treatment is ineffective.
A more accurate interpretation is:
“There may be benefit, but further research is needed to determine which patients should receive it, how it should be delivered, and to what extent.”
This distinction is particularly important in female hair loss.
06
Selecting candidates for female hair transplantation
Hair transplantation can also have a role in selected patients
Hair transplantation may be considered for women who find it difficult to achieve their desired result with medication or non-surgical treatments alone.
However, not every woman with hair loss is a candidate for surgery.
The review emphasizes the importance of checking whether sufficient thick, stable hair remains at the back of the head. Surgery may be unsuitable when thinning is widespread, including in the donor area. Even after transplantation, treatment is still needed to manage the progression of existing hair loss.[1]
Hair transplantation should therefore be understood as one option within a long-term, individualized treatment plan, rather than the opposite of medical treatment.
FIG. 08What to assess before and after transplantation
Occipital donor areaAssess thickness and stability
01
Donor hair thickness and stability
Check whether sufficient thick, stable hair remains in the donor area.
02
Thinning within the donor area
Surgery may be unsuitable when the donor hair is also diffusely thinned.
03
Managing existing hair after surgery
Even after surgery, a long-term plan to manage progressive hair loss remains necessary.
A simplified illustration of donor-area location, not an actual harvesting boundary.
AN INDIVIDUAL TREATMENT PLAN
Female hair loss treatment is not a search for one universal answer
The central message of this 2023 review is not that minoxidil is the only treatment that should be used.
Minoxidil is the best-supported starting point, but not every patient responds sufficiently, and other treatments also have clinical evidence worth considering.
In practice, the more important question is therefore not “Which treatment is best?” but “Which treatment, or combination of treatments, is most appropriate for this patient now?”
Even among women with the same pattern of hair loss, age, progression, remaining hair, response to previous treatment, associated hormonal problems, pregnancy potential, and preferences all differ.
FIG. 09The individual is at the center of the treatment plan
AgeExtent of progressionRemaining hairPrevious treatment responseHormonal factorsPregnancy potentialTreatment preferences
The appropriate treatment and combination for this patient
Female hair loss treatment can be viewed as starting with minoxidil as a standard treatment, then rationally broadening the options according to the response and individual circumstances—to oral medication, adjunctive procedures, light therapy, and, when appropriate, hair transplantation.
References
Ramos PM, Melo DF, Radwanski H, et al. Female-pattern hair loss: therapeutic update. Anais Brasileiros de Dermatologia. 2023;98(4):506–519. DOI: 10.1016/j.abd.2022.09.006.Read the article on PMC ↗ · DOI ↗
Dubin DP, Lin MJ, Leight HM, et al. The effect of platelet-rich plasma on female androgenetic alopecia: A randomized controlled trial. Journal of the American Academy of Dermatology. 2020;83(5):1294–1297. DOI: 10.1016/j.jaad.2020.06.1021.See the PRP study’s 24-week assessment ↗
FAQ
QIs minoxidil alone enough to treat female hair loss?
ATopical minoxidil has the strongest body of evidence for female pattern hair loss, but not every patient responds sufficiently. If the response is inadequate, daily application is difficult, or scalp irritation occurs, the diagnosis and response can be reassessed before considering other medications or adjunctive treatments.
QIs oral minoxidil better than topical minoxidil?
AIt cannot be considered better for every patient. In the comparison study discussed in the article, both treatments increased hair density, with no statistically significant difference between them. Oral minoxidil may cause excessive hair growth, swelling and palpitations. A clinician should determine whether it is appropriate and select the dose.
QCan women use hair loss medications that modify hormonal influences?
AThey may be considered in selected patients, but treatment used for male pattern hair loss should not simply be applied to women in the same way. Age, menopausal status, signs of excess androgens and pregnancy potential need to be assessed. Some antiandrogen treatments have restrictions for women who could become pregnant, so an individual medical assessment is necessary.
QIs there evidence for PRP, microneedling or light therapy in female hair loss?
APositive clinical findings have been reported, and these treatments may be considered as adjuncts. However, their evidence is not equivalent. PRP preparation, concentration and treatment frequency are not standardized, while microneedling research remains limited in quality and scale. Treatment should be selected with both its potential benefits and limitations in mind.
QCan women with hair loss have a hair transplant?
AHair transplantation may be considered in selected patients. Sufficient thick, stable hair must remain in the occipital donor area. Surgery may be unsuitable if thinning is widespread, including in that area. Even after transplantation, a long-term plan is still needed to manage progression of the existing hair loss.
